Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 21, 2016 08:00 ET | Source: Actinium Pharmaceuticals

Actinium Pharmaceuticals to Host Webinar to Provide Update on Actimab-A Phase 2 Clinical Trial

- Webinar to be Held on Tuesday, September 27, 2016 at 9:00 AM ET - Webinar to feature Principle Investigator Joseph Jurcic, M.D., Professor of Clinical Medicine and Director of the Hematologic...
September 20, 2016 07:00 ET | Source: Actinium Pharmaceuticals

Actinium Pharmaceuticals Selects Vector Oncology as its Clinical Research Organization for Actimab-A Phase 2 Trial

NEW YORK, Sept. 20, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
September 19, 2016 07:00 ET | Source: Actinium Pharmaceuticals

Actinium Pharmaceuticals to Present at Ladenburg Thalmann 2nd Annual Healthcare Conference

- Actinium to Present on Tuesday, September 27, 2016 at 1:00 PM ET - Management Will be Available for 1-on-1 Meetings with Conference Attendees NEW YORK, Sept. 19, 2016 (GLOBE NEWSWIRE) --...
September 13, 2016 07:00 ET | Source: Actinium Pharmaceuticals

Actinium Pharmaceuticals Presenting at Rodman & Renshaw 18th Annual Global Investment Conference

Company to Present on Tuesday, September 13, 2016 at 10:25 AM ET Presentation can be viewed via webcast NEW YORK, Sept. 13, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE...
September 09, 2016 07:00 ET | Source: Actinium Pharmaceuticals

Actinium Pharmaceuticals Presenting at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference

Company Presentation Scheduled for Friday, September 9, 2016 at 2:30 PM ET Presentation can be viewed via webcast NEW YORK, Sept. 09, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals,...
September 07, 2016 07:00 ET | Source: Actinium Pharmaceuticals

Actinium Enhances Capabilities with Hiring of Industry and Clinical Research Veterans to its Product Development and Clinical Development Teams

NEW YORK, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...